A task force details its findings of the risks associated with using convalescent plasma using failure mode and effects analysis
Smita Kale
Advertisement
Smita Kale is associate manager at the Venture Center, Pune, India.
Articles by Smita Kale
Advertisement
Latest Updated Articles
- A Systematic Evaluation of Risks and Mitigation Strategies for Convalescent Plasma Therapy for COVID-19
Published: February 3rd 2021 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
2025 PharmSci 360 to Showcase Essential AI Integration and Emerging Technologies
2
Top 10 Questions from CPHI Frankfurt: Building Pharma Resilience a Common Theme
3
Pharma Tariff FAQ: Costs, Supply Chains, Policy for 2025
4
A Simple Step-by-Step Protocol for Hydrophilic Interaction Liquid Chromatography (HILIC) Development
5
